Submitted by Anonymous (not verified) on 14 September 2026 - 14:44
Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation: 08/01/2018, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation: 08/01/2018, Revision: 17, Status: Authorised